| Click above for member login and renew options |
GOLD MEMBERS
Our mission is to deliver breakthrough innovations that extend and improve the lives of people with cancer. We are working to prevent cancer where we can and give patients more ways to treat their cancer, more quality in their lives and more time. Everyone knows someone who has been touched by cancer. When that diagnosis happens, what matters most isn't what the next breakthrough is - but when it will get here. |
Together, we work to accelerate innovation, enhance patient access to medicines, build an inclusive, diverse and equitable work environment, and strengthen our environmental sustainability — all while operating with the highest levels of quality, integrity and ethics. |
SILVER MEMBERS
The mission of Taiho Oncology, Inc. is to improve the lives of patients with cancer, their families and their caregivers. The company specializes in the development and commercialization of orally administered anti-cancer agents for various tumor types. Taiho Oncology has a robust pipeline of small molecule clinical candidates targeting solid tumor and hematological malignancies, with additional candidates in pre-clinical development. Taiho Oncology is a subsidiary of Taiho Pharmaceutical Co., Ltd. which is part of Otsuka Holdings Co., Ltd. Taiho Oncology is headquartered in Princeton, New Jersey and oversees its parent company’s European and Canadian operations, which are located in Zug, Switzerland and Oakville, Ontario, Canada. Follow us on LinkedIn and Twitter. |
BRONZE MEMBER |
We’re a medicine company turning science into healing to make life better for people around the world. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing science to solve some of the world's most significant health challenges. It all started nearly 150 years ago with a clear vision from founder Colonel Eli Lilly: "Take what you find here and make it better and better." |
Our mission is to use the power of science to bring new medicines to patients ... over and over again. We are a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Regeneron's medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases and rare diseases. |